• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review - Product Image

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review

  • ID: 1322588
  • April 2014
  • 41 pages
  • GlobalData

FEATURED COMPANIES

  • Allergan, Inc.
  • Pfizer Inc.
  • Targacept, Inc.
  • MORE

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees READ MORE >

FEATURED COMPANIES

  • Allergan, Inc.
  • Pfizer Inc.
  • Targacept, Inc.
  • MORE

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Acadia Pharmaceuticals Inc. - Key Facts
Acadia Pharmaceuticals Inc. - Key Employees
Acadia Pharmaceuticals Inc. - Key Employee Biographies
Acadia Pharmaceuticals Inc. - Major Products and Services
Acadia Pharmaceuticals Inc. - Pharmaceutical Pipeline Products Data
Acadia Pharmaceuticals Inc., Pipeline Products by Therapy Area
Acadia Pharmaceuticals Inc., Pipeline Products by Development Phase
Acadia Pharmaceuticals Inc. - History
Acadia Pharmaceuticals Inc. - Company Statement
Acadia Pharmaceuticals Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Acadia Pharmaceuticals Inc. - Business Description
Acadia Pharmaceuticals Inc. - Corporate Strategy
Acadia Pharmaceuticals Inc. - SWOT Analysis
SWOT Analysis - Overview
Acadia Pharmaceuticals Inc. - Strengths
Strength - Focused Research and Development
Strength - Strong Patent Portfolio
Strength - Technological base
Acadia Pharmaceuticals Inc. - Weaknesses
Weakness - Lack of Product Based Revenue
Weakness - Lack of Manufacturing Facilities
Acadia Pharmaceuticals Inc. - Opportunities
Opportunity - Strong Product Pipeline
Opportunity - Market Potential – CNS Therapy
Opportunity - Changing Demographics
Acadia Pharmaceuticals Inc. - Threats
Threat - Intense Competition
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Acadia Pharmaceuticals Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Acadia Pharmaceuticals Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Acadia Pharmaceuticals Inc., Recent Developments
Feb 27, 2014: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013
Nov 26, 2013: ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 06, 2013: ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results
Oct 30, 2013: ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013
Sep 03, 2013: ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 19, 2013: ACADIA Pharmaceuticals Announces Appointment of Terrence Moore as Executive Vice President and Chief Commercial Officer
Aug 06, 2013: ACADIA Pharmaceuticals Reports Second Quarter 2013 Financial Results
Jul 30, 2013: ACADIA Pharmaceuticals to Announce Second Quarter 2013 Financial Results on August 6, 2013
Jul 01, 2013: ACADIA Pharmaceuticals Added to Russell 2000 Index
Jun 03, 2013: Acadia Pharma's Partner Allergan Advances New Glaucoma Compound Into Preclinical Development
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Acadia Pharmaceuticals Inc., Key Facts
Acadia Pharmaceuticals Inc., Key Employees
Acadia Pharmaceuticals Inc., Key Employee Biographies
Acadia Pharmaceuticals Inc., Major Products and Services
Acadia Pharmaceuticals Inc., Number of Pipeline Products by Therapy Area
Acadia Pharmaceuticals Inc., Number of Pipeline Products by Development Stage
Acadia Pharmaceuticals Inc., Pipeline Products By Therapy Area and Development Phase
Acadia Pharmaceuticals Inc., History
Acadia Pharmaceuticals Inc., Subsidiaries
Acadia Pharmaceuticals Inc., Key Competitors
Acadia Pharmaceuticals Inc., Ratios based on current share price
Acadia Pharmaceuticals Inc., Annual Ratios
Acadia Pharmaceuticals Inc., Interim Ratios
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Acadia Pharmaceuticals Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Acadia Pharmaceuticals Inc., Pipeline Products by Therapy Area
Acadia Pharmaceuticals Inc., Pipeline Products by Development Phase
Acadia Pharmaceuticals Inc., Performance Chart (2009 - 2013)
Acadia Pharmaceuticals Inc., Ratio Charts
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014

Alseres Pharmaceuticals, Inc.
Targacept, Inc.
Vanda Pharmaceuticals Inc.
Allergan, Inc.
Pfizer Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS